20.4 C
mercredi, février 8, 2023
Home Tags Heart failure

Tag: Heart failure

In this chat, we'll discuss how Temple is helping patients regain their quality of life through the diagnosis and treatment of advanced heart failure.
Mesoblast (MESO) Announces Phase 3 Study Results of Rexlemestrocel-L in 565 New York Heart Association ((NYHA)) Class II and Class III Chronic Heart Failure Patients ...
Insane Clown Posse a annoncé que leur tournée 2022 serait la dernière du duo, alors que Violent J révélait ses graves problèmes cardiaques. Au cours du Gathering of the Juggalos ce week-end à Legend Valley à Thornville, Ohio,...
. . Mesoblast Ltd (ASX: MSB) stocks took a heavy blow today on the results of the third phase of chronic heart failure for their Rexlemestrocel-L therapy. Mesoblast stock's price has done reasonably well this year, despite having experienced significant volatility. . .
. . The stock fell more than 10 percent after the stem cell therapy group missed its primary endpoint in a study to treat Revascor chronic heart failure.
. . Mesoblast Limited (ASX: MSB) stock price fell on Tuesday. Here's what you need to know. . .
. . The BioCardia (BCDA) news for Monday includes an announcement of preliminary results from clinical trials that are increasing the BCDA inventory.
Ce site, comme beaucoup d’autres, utilise des petits fichiers appelés cookies pour nous aider à améliorer et personnaliser votre expérience.
Privacy Policy